Detectnet FDA Approval History
Last updated by Judith Stewart, BPharm on Oct 27, 2020.
FDA Approved: Yes (First approved September 3, 2020)
Brand name: Detectnet
Generic name: copper Cu 64 dotatate
Dosage form: Injection
Company: RadioMedix Inc.
Treatment for: Positron Emission Tomography Imaging
Detectnet (copper Cu 64 dotatate) is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult patients.
Development timeline for Detectnet
| Date | Article |
|---|---|
| Sep 8, 2020 | Approval FDA Approves Detectnet (copper Cu 64 dotatate injection) Positron Emission Tomography (PET) Agent |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.